Clinical Trials Browser

Phase 2 × Ezetimibe × 30 days × Clear all

NCT06437574 2026-03-11

Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms